{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0310-9400",
      "generic_name": "EPLONTERSEN",
      "labeler_name": "AstraZeneca Pharmaceuticals LP",
      "brand_name": "WAINUA",
      "active_ingredients": [
        {
          "name": "EPLONTERSEN",
          "strength": "45 mg/.8mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0310-9400-01",
          "description": "1 SYRINGE, GLASS in 1 CARTON (0310-9400-01)  / .8 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20231221",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "AstraZeneca Pharmaceuticals LP"
        ],
        "rxcui": [
          "2671944",
          "2671950",
          "2741485",
          "2741488"
        ],
        "spl_set_id": [
          "d7dcb847-71dd-4fff-82d0-d43a465fc096"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193849",
          "N0000191626",
          "M0025055",
          "N0000008852",
          "N0000009531"
        ],
        "pharm_class_epc": [
          "Transthyretin-directed RNA Interaction [EPC]",
          "Antisense Oligonucleotide [EPC]"
        ],
        "pharm_class_cs": [
          "Oligonucleotides, Antisense [CS]"
        ],
        "pharm_class_pe": [
          "Decreased RNA Integrity [PE]",
          "Increased Protein Breakdown [PE]"
        ],
        "unii": [
          "0GRZ0F5XJ6"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "cea076d0-c827-4c46-9b36-418bf63d5a9d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20231221",
      "product_id": "0310-9400_cea076d0-c827-4c46-9b36-418bf63d5a9d",
      "application_number": "NDA217388",
      "brand_name_base": "WAINUA",
      "pharm_class": [
        "Antisense Oligonucleotide [EPC]",
        "Decreased RNA Integrity [PE]",
        "Increased Protein Breakdown [PE]",
        "Oligonucleotides",
        "Antisense [CS]",
        "Transthyretin-directed RNA Interaction [EPC]"
      ]
    }
  ]
}